Wednesday, March 25th at 11:00 AM CT
VIN Portfolio Company Highlight: Solaris Vaccines
Solaris Vaccines is dedicated to transforming global health by developing safer, more effective vaccines through its breakthrough SolaVAX™ platform. By utilizing a natural process involving Vitamin B2 and UV light to prepare pathogens, the company creates vaccines that trigger a robust immune response without the use of harsh chemicals or complex additives. This innovative approach streamlines the manufacturing process, making it possible to produce high-quality vaccines more quickly and affordably than traditional methods. Focused on addressing both current and emerging infectious diseases, Solaris Vaccines is committed to providing scalable, accessible immunization solutions that protect communities worldwide.